Anelca Clinic Limited 03551237 false 2023-07-01 2024-06-30 2024-06-30 The principal activity of the company is that of providing plastic surgery. Digita Accounts Production Advanced 6.30.9574.0 true 03551237 2023-07-01 2024-06-30 03551237 2024-06-30 03551237 bus:OrdinaryShareClass1 2024-06-30 03551237 core:RetainedEarningsAccumulatedLosses 2024-06-30 03551237 core:ShareCapital 2024-06-30 03551237 core:CurrentFinancialInstruments 2024-06-30 03551237 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 03551237 core:FurnitureFittings 2024-06-30 03551237 core:OfficeEquipment 2024-06-30 03551237 core:PlantMachinery 2024-06-30 03551237 bus:SmallEntities 2023-07-01 2024-06-30 03551237 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 03551237 bus:AbridgedAccounts 2023-07-01 2024-06-30 03551237 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 03551237 bus:RegisteredOffice 2023-07-01 2024-06-30 03551237 bus:CompanySecretaryDirector2 2023-07-01 2024-06-30 03551237 bus:Director1 2023-07-01 2024-06-30 03551237 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 03551237 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 03551237 core:ComputerEquipment 2023-07-01 2024-06-30 03551237 core:FurnitureFittings 2023-07-01 2024-06-30 03551237 core:OfficeEquipment 2023-07-01 2024-06-30 03551237 core:PlantMachinery 2023-07-01 2024-06-30 03551237 countries:AllCountries 2023-07-01 2024-06-30 03551237 2023-06-30 03551237 core:FurnitureFittings 2023-06-30 03551237 core:OfficeEquipment 2023-06-30 03551237 core:PlantMachinery 2023-06-30 03551237 2022-07-01 2023-06-30 03551237 2023-06-30 03551237 bus:OrdinaryShareClass1 2023-06-30 03551237 core:RetainedEarningsAccumulatedLosses 2023-06-30 03551237 core:ShareCapital 2023-06-30 03551237 core:CurrentFinancialInstruments 2023-06-30 03551237 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 03551237 core:FurnitureFittings 2023-06-30 03551237 core:OfficeEquipment 2023-06-30 03551237 core:PlantMachinery 2023-06-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03551237

Anelca Clinic Limited

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 30 June 2024

 

Anelca Clinic Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 6

 

Anelca Clinic Limited

Company Information

Directors

Dr LC Andersson

Mr SGM Ohlin

Company secretary

Mr SGM Ohlin

Registered office

Suite 1B1 Argyle House
Northside
Joel Street
Northwood Hills
HA6 1NW

Accountants

Ross + Partners
Chartered Certified Accountants
Suite 1B1 Argyle House
Northside
Joel Street
Northwood Hills
HA6 1NW

 

Anelca Clinic Limited

(Registration number: 03551237)
Abridged Balance Sheet as at 30 June 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

3

2,379

3,613

Current assets

 

Stocks

54,100

45,100

Debtors

86,237

89,597

Cash at bank and in hand

 

-

280

 

140,337

134,977

Creditors: Amounts falling due within one year

(63,669)

(60,179)

Net current assets

 

76,668

74,798

Net assets

 

79,047

78,411

Capital and reserves

 

Called up share capital

100

100

Retained earnings

78,947

78,311

Shareholders' funds

 

79,047

78,411

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 25 March 2025 and signed on its behalf by:
 

 

Anelca Clinic Limited

(Registration number: 03551237)
Abridged Balance Sheet as at 30 June 2024

.........................................
Dr LC Andersson
Director

   
     
 

Anelca Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2024

1

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Anelca Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Equipment

20% on reducing balance

Fixtures and fittings

20% on reducing balance

Computer equipment

33.3% on cost

Stocks

Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2023 - 5).

 

Anelca Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2024

3

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 July 2023

89,205

9,740

27,088

126,033

At 30 June 2024

89,205

9,740

27,088

126,033

Depreciation

At 1 July 2023

87,561

9,357

25,502

122,420

Charge for the year

329

77

828

1,234

At 30 June 2024

87,890

9,434

26,330

123,654

Carrying amount

At 30 June 2024

1,315

306

758

2,379

At 30 June 2023

1,644

383

1,586

3,613

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100